Doç. Dr. Mehmet Naci Aldemir

Yayın Ağı

Makaleler 36

1. Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer

Sezgin Y., Karhan O., Aldemir M. N., Ürün M., Erçek B. M., Urakcı Z., et al.

Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)

2. Definitive chemoradiotherapy versus upfront surgery in locoregional esophageal squamous cell cancer

KALKAN N. Ö., MERT A. G., ÇAKIROĞLU U., ALDEMİR M. N., KOTAN Ç.

Annals of Medical Research , cilt.31, sa.11, ss.898-904, 2024 (TRDizin)

3. Testis Kanserinde Prognostik Faktörler

Sezgin Y., Karhan O., Biçer A., İleri S., Yerlikaya H., Tunç S., et al.

Turkish Journal of Clinics and Laboratory , cilt.15, sa.2, ss.176-181, 2024 (TRDizin)

4. EFFECT OF TAXIFOLIN ON DOXORUBICIN-INDUCED OXIDATIVE CARDIAC DAMAGE IN RATS: A BIOCHEMICAL AND HISTOPATHOLOGICAL EVALUATION

Aldemir M. N., Kara A., Mammadov R., Yazici G., Cicek B., Yavuzer B., et al.

Journal of Animal and Plant Sciences , cilt.34, sa.1, ss.99-106, 2024 (SCI-Expanded, Scopus)

5. Factors affecting survival in operated gastric cancer

Sakin A., Sahin S., Sakin A., Aldemir M. N., Sakoglu N., Bayram İ., et al.

Surgical Oncology , cilt.46, 2023 (SCI-Expanded, Scopus)

6. The prognostic effect of pretreatment 18F-FDG PET/CT metabolic parameters in locally advanced Esophageal Squamous Cell Carcinoma treated with definitive chemoradiotherapy

Sakin A., Özçelik M., Sahin S., Aydemir O., Aldemir M. N., İliklerden Ü. H., et al.

SURGICAL ONCOLOGY-OXFORD , cilt.43, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Factors Affecting Survival in Operated Esophageal Squamous Cell Carcinoma

Akgül N., Sakin A., Sahin S., Aldemir M. N., Aytekin A., Alay M., et al.

JOURNAL OF GASTROINTESTINAL CANCER , cilt.53, sa.2, ss.439-445, 2022 (ESCI, Scopus)

8. Chemoradiotherapy followed by surgery versus observation in esophageal squamous cell carcinoma.

SAKİN A., SAHİN S., ALDEMİR M. N., İLİKLERDEN Ü. H., KOTAN M. Ç.

JOURNAL OF B.U.ON. , cilt.26, sa.4, ss.1509-1516, 2021 (SCI-Expanded, Scopus)

9. Chemoradiotherapy followed by surgery versus observation in esophageal squamous cell carcinoma

SAKİN A., ŞAHİN S., ALDEMİR M. N., İLİKLERDEN Ü. H., KOTAN M. Ç.

Journal of BUON , cilt.26, sa.4, ss.1509-1516, 2021 (Scopus)

10. The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy

Sakin A., Atci M. M., Aldemir M. N., Akagunduz B., Sahin S., Arici S., et al.

CUREUS , cilt.13, sa.4, 2021 (ESCI)

11. Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma

Sakin A., Alay M., Sahin S., Aydemir O., Aldemir M. N., Sakin A., et al.

NORTHERN CLINICS OF ISTANBUL , cilt.8, sa.5, ss.435-442, 2021 (ESCI, TRDizin)

12. Lymph Node Ratio Predicts Long-Term Survival in Lymph Node-Positive Breast Cancer

Sakin A., Aldemir M. N.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.16, sa.4, ss.270-275, 2020 (ESCI, TRDizin) Sürdürülebilir Kalkınma

13. Factors Affecting Recurrence-free Survival in Gastric Gastrointestinal Stromal Tumors: A Single Center Experience

Sakin A., Aldemir M. N.

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI , cilt.58, sa.4, ss.327-332, 2020 (ESCI, Scopus, TRDizin)

14. Red Blood Cell Distribution Width as a Possible Predictor of Diagnosis and Survival in Gastric Cancer

Sakin A., Aydemir O., Şahin S., Alay M., Aytekin A., Aldemir M. N., et al.

Eurasian Journal of Medical Investigation , cilt.4, sa.3, ss.289-297, 2020 (TRDizin) Sürdürülebilir Kalkınma

15. Rare Breast Malignancies

Yildirim N., Aldemir M. N., Simsek M., BİLİCİ M., TEKİN S. B.

MEDICAL JOURNAL OF BAKIRKOY , cilt.15, sa.3, ss.232-239, 2019 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

16. Relationship between 18-FDG-PET/CT and Clinicopathological Features and Pathological Responses in Patients with Locally Advanced Breast Cancers.

YILDIRIM N., SIMSEK M., Aldemir M. N., BILICI M., TEKIN S.

The Eurasian journal of medicine , cilt.51, ss.154-159, 2019 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

17. Protective Effect of Taxifolin on Cisplatin-Induced Nephrotoxicity in Rats

Kara A. V., Aldemir M. N., ÖZÇİÇEK F., MAMMADOV R., YAZICI G. N., SUNAR M., et al.

ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY , cilt.41, sa.2, ss.47-54, 2019 (SCI-Expanded, Scopus)

18. Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients.

KARA A., YıLDıRıM Y., OZCICEK F., Aldemir M. N., ARSLAN Y., BAYAN K., et al.

Acta gastro-enterologica Belgica , cilt.82, ss.273-277, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Relationship between Serum Vitamin D Levels and Health-Related Quality of Life in Maintenance Hemodialysis Patients.

KARA A., Aldemir M. N., SOYLU Y., ARSLAN Y.

Blood purification , cilt.48, ss.67-75, 2019 (SCI-Expanded, Scopus)

20. Mucinous Breast Carcinoma: A Single-Center Experience

YILDIRIM N., Aldemir M. N.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.33, sa.2, ss.43-47, 2018 (ESCI, Scopus, TRDizin)

21. Maternal and fetal outcomes of malignancies diagnosed during pregnancy: a single center's ten-year experiences

Turkeli M., YILDIRIM N., Simsek M., ALDEMİR M. N., TEKİN S. B.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , cilt.38, sa.6, ss.849-853, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Gastrointestinal Stromal Tumors: A Single Center Experience

YILDIRIM N., Simsek M., Aldemir M. N., BİLİCİ M., Basol Tekin S.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.32, sa.1, ss.19-24, 2017 (ESCI, Scopus, TRDizin)

23. Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience.

TURKELI M., SIMSEK M., Aldemir M. N., YILDIRIM N., CANKAYA E., ERDEMCI B., et al.

The Eurasian journal of medicine , cilt.48, ss.33-6, 2016 (ESCI, Scopus, TRDizin)

24. EFFICACY AND TOLERABILITY OF CHEMOTHERAPY IN ELDERLY PATIENTS WITH METASTATIC GASTRIC CANCER

Turkeli M., Aldemir M. N., Simsek M., Yildirim N., BİLİCİ M., CAYIR K., et al.

TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI , cilt.19, sa.1, ss.27-34, 2016 (SCI-Expanded, SSCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

25. A morphometric study of the protective effect of cryotherapy on oral mucositis in cancer patients treated with 5-fluorouracil

Turkeli M., ALDEMİR M. N., Bingol F., Dogan C., KARA A.

BIOTECHNIC & HISTOCHEMISTRY , cilt.91, sa.7, ss.465-471, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. MULTICENTRIC BONE INVOLVEMENT AND COMPLETE RESPONSE TO CHEMOTHERAPY: A CASE REPORT

Simsek M., Turkeli M., Aldemir M. N., Yildirim N., TEKİN S. B., BİLİCİ M.

ACTA MEDICA MEDITERRANEA , cilt.32, sa.1, ss.163-166, 2016 (SCI-Expanded, Scopus)

27. Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma.

TURAN N. B., BENEKLI M., UNAL O., UNEK İ., TASTEKIN D., DANE F., et al.

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu , cilt.27, ss.408-16, 2015 (SCI-Expanded, Scopus)

28. Prognostic Value of Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Local and Advanced Gastric Cancer Patients.

Aldemir M. N., TURKELI M., SIMSEK M., YILDIRIM N., BILEN Y., YETIMOGLU H., et al.

Asian Pacific journal of cancer prevention : APJCP , cilt.16, ss.5933-7, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.

TURKELI M., Aldemir M. N., CAYIR K., SIMSEK M., BILICI M., TEKIN S., et al.

Asian Pacific journal of cancer prevention : APJCP , cilt.16, ss.985-9, 2015 (SCI-Expanded, Scopus)

30. Abnormal liver function test in hydatidiform moles: a retrospective study comparing the hyperthyroid state and the euthyroid state.

KUCUKOGLU M., DULGER A. C., ASLAN M., OLMEZ S., GULER A., Aldemir M. N., et al.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology , cilt.30, ss.287-9, 2014 (SCI-Expanded, Scopus)

31. Peripheral blood levels of cellular and humoral immunity parameters in esophageal and gastric cancer patients

Begenik H., Turkdogan M. K., Dulger A. C., Aldemir M. N., Esen R., Mete R.

CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY , cilt.38, sa.3, ss.355-357, 2013 (SCI-Expanded, Scopus)

32. Relationship between visfatin and some clinical and biochemical parametres in peritoneal dialysis patients.

SOYORAL Y., ERKOC R., BEGENIK H., Aldemir M. N., KUCUKOGLU M.

JPMA. The Journal of the Pakistan Medical Association , cilt.62, ss.1179-83, 2012 (SCI-Expanded, Scopus)

33. Skin Bleeding Time for the Evaluation of Uremic Platelet Dysfunction and Effect of Dialysis

SOYORAL Y. U., Demir C., Begenik H., Esen R., KUCUKOGLU M. E., Aldemir M. N., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.18, sa.2, ss.185-188, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Amlodipine-induced gingival hyperplasia in chronic renal failure: a case report

Aldemir N. M., BEGENIK H., EMRE H., ERDUR F. M., SOYORAL Y.

AFRICAN HEALTH SCIENCES , cilt.12, sa.4, ss.576-578, 2012 (SCI-Expanded, Scopus)

35. The course of hypercalciuria and related markers of bone metabolism parameters associated with corticosteroid treatment.

DUZEN O., ERKOC R., BEGENIK H., SOYORAL Y., Aldemir M. N.

Renal failure , cilt.34, ss.338-42, 2012 (SCI-Expanded, Scopus)

36. Comparison of the Automated Cell Counter and Manual Method for the Assessment of Dialysis Fluids in Peritoneal Dialysis Patients

SOYORAL Y. U., Begenik H., Aldemir M. N., Baran A. İ., Emre H., KARAHOCAGIL M. K., et al.

HEALTHMED , cilt.5, sa.6, ss.1891-1894, 2011 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. Efficacy and tolerability of first-line chemotherapy in elderly patients ( age >= 70 years) with metastatic gastric cancer: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)

ALDEMİR M. N., Turkeli M., Hacioglu B., SAKIN A., Yaman E., Coban E., et al.

41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Danimarka, 7 - 11 Ekim 2016, cilt.27, (Özet Bildiri) Sürdürülebilir Kalkınma

Kitaplar 3

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

152

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Toplam Atıf Sayısı

154

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler